Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Special Drug Use-Results Survey of Evaluating Safety and Effectiveness of Humira in Long Term Treatment in Patients With Hidradenitis Suppurativa

NCT03894956 is registered in ClinicalTrials.gov with AbbVie as lead sponsor.

NCT NCT03894956
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03894956 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Special Drug Use-Results Survey of Evaluating Safety and Effectiveness of Humira in Long Term Treatment in Patients With Hidradenitis Suppurativa
Lead sponsor
AbbVie
Phase
Observational
Overall status
Completed
Start date
May 2, 2019
Completion date
November 10, 2021
Enrollment
46 (actual)
Sites
37

Conditions

As the registry lists them; a condition with its own page is linked.

hidradenitis suppurativa (hs)